US Patent Litigations are now available. Check here

IP Verse

Methods For Isolating Blood Products From An Inter-Alpha Inhibitor Protein-Depleted Blood Product Material

PatentPatent Analysis

EP2945962

PROTHERA BIOLOGICS
Application Number
EP14740523A
Filing Date
Jan 17, 2014
Status
Revoked
Jun 23, 2023
Grant Date
Apr 17, 2019
External Links
Slate, Register, Google Patents

Biblio Summary

The patent EP2945962B1 was granted on Apr 17, 2019 by Prothera Biologics The patent is currently Revoked.

Patents Cited during Opposition New

Patent citations in opposition refer to prior patents or publications that may challenge the validity of a contested patent. These references help assess whether the invention is truly novel or overlaps with existing intellectual property.

Citation PhasePatent NumberPatent LinkCited Text
OppositionWO9429334
 N/A
OppositionUS4395396
 N/A
OppositionUS4510084
 N/A
OppositionWO8905650
 N/A
OppositionUS5457181
 N/A
OppositionWO9610584
 N/A
OppositionUS6069236
 N/A
OppositionWO0230983
 N/A
OppositionWO2005046587
 N/A
OppositionWO2005121163
 N/A
OppositionCN101274956
 N/A
OppositionUS2009292114
 N/A
OppositionUS2011190194
 N/A
OppositionUS2011293594
 N/A
OppositionWO2012012773
 N/A
OppositionUS2012053325
 N/A

Dossier Documents of the Patent

The dossier documents provide a comprehensive record of the patent’s prosecution history, including filings, correspondence, and decisions made by patent offices. These documents are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination. It also includes the oppositions documents filed against the patent.

  • Date

    Description

  • Get instant alerts for new documents